cephalexin has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, LM; Liu, L; Liu, PH; Liu, XD; Qin, L; Xu, F; Zhou, JJ | 1 |
| Sato, J; Terada, K; Watanabe, K | 1 |
2 other study(ies) available for cephalexin and Alloxan Diabetes
| Article | Year |
|---|---|
Diabetes downregulates peptide transporter 1 in the rat jejunum: possible involvement of cholate-induced FXR activation.
Topics: Animals; Caco-2 Cells; Cephalexin; Cholic Acids; Diabetes Mellitus, Experimental; Down-Regulation; Humans; Jejunum; Peptide Transporter 1; Rats; Receptors, Cytoplasmic and Nuclear; Valacyclovir | 2020 |
Intestinal absorption of cephalexin in diabetes mellitus model rats.
Topics: Animals; Carrier Proteins; Cephalexin; Diabetes Mellitus, Experimental; Disease Models, Animal; Intestinal Absorption; Male; Peptide Transporter 1; Rats; Rats, Wistar; Rats, Zucker; Symporters | 2003 |